SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Ivonescimabs Phase III HARMONi-GI1 results in advanced biliary tract cancer are drawing attention: the trial showed a survival benefit versus durvalumab plus chemotherapy, but traders disagree on how meaningful the result is given the interim, China-only data. Some see it as validation of the drug and its broader potential, while others are focused on the upcoming U.S. FDA decision for ivonescimab in lung cancer.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Nateras strong run to fresh highs is driving attention, with traders pointing to rising test volumes and oncology growth, including Signatera and the FDA Breakthrough Device designation for its investigational early-cancer assay. Sentiment is broadly bullish, though some traders warn the stock looks extended and expect profit-taking or a pullback.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Volatile BCH price action is driving discussion, with traders divided between expecting a rebound and warning of further declines. Some bullish traders point to the anticipated CashVM/Layla upgrade as a catalyst, while skeptics question the coins utility and momentum.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp, apparently news-free price spike has put XCN in focus, with traders debating whether it reflects genuine momentum or another short-lived pump-and-dump move. Some are buying the dip, while others expect the gains to fade; a few link possible upside to Bitcoins rebound.

Mattel, Inc. engages in the ownership of children's and family entertainment franchises. It operates through the following segments: North America, International, and American Girl. The North America and International segments focus on marketing and selling toys and consumer products. The American Girl segment includes marketing, retailing, and publishing dedicated to its mission to help girls grow up with confidence and character. The company was founded by Elliot Handler, Ruth Handler, and Harold Matson in 1945 and is headquartered in El Segundo, CA.

Mattel, Inc.

Mattels holiday-quarter results fell short of expectations and its 2026 outlook disappointed, triggering a sharp selloff. Traders are split between viewing the drop and planned buybacks as a buying opportunity and worrying that softer demand and margin pressure signal continued weakness.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Traders are focused on Compounds reported $52 million institutional finance initiative, leadership changes and institutional-market launch, which bullish holders see as a possible turnaround for the DeFi token. Skeptics counter that COMP has continued to lag other cryptocurrencies, and recent sharp price swings have prompted questions about the selloff and dip-buying.

Canton Coin (CC), the network’s native utility token, was designed to reward real network usage over speculation. It aligns the success of the network with the participants who make it work, fairly rewarding app builders and app users, as well as those operating decentralized infrastructure. The result is a fundamentally different model where rewards flow to those creating value through real activity, not only miners or early investors.

Canton

Canton Coin is drawing attention around the networks institutional adoption and tokenization plans, particularly DTCCs planned use of Canton and high-profile validator and partnership additions. Traders are bullish on the infrastructures potential, while others question whether that adoption will translate into token appreciation given ongoing issuance and unlocks.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results, sharply reduced annual outlook and dividend suspension have fueled attention, with the company citing recession-level appliance demand and the Iran war among the pressures. Traders largely criticize management and fear further declines or financial distress, while some see the selloff as a potential value opportunity or bounce setup.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Positive Phase 3 lung-cancer data for Amgens Imdelltra combined with AstraZenecas Imfinzi is drawing attention, with traders highlighting the reported survival benefit and viewing oncology as an important driver of AZNs growth story.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys Q3 report and stronger-than-expected Q4 profit outlook are driving attention: shares rallied despite revenue and EPS misses, as traders focused on subscriber growth, expanding gross margins and improved ad growth. The bullish reaction is tempered by concerns about rising expenses and weaker free cash flow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +200.00% and +7.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests

Key Points10,000 Common Stock shares were sold for a transaction value of $402,000 at an average price of around $40.24 per share on June 18, 2026...

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More...

Vericel (VCEL) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates

Vericel (VCEL) delivered earnings and revenue surprises of +17.24% and +7.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 53.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Conestoga Capital Advisors LLC Acquires 79,278 Shares of Vericel Corporation $VCEL

Conestoga Capital Advisors LLC grew its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the...

Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor

Vericel (NASDAQ:VCEL) held its 2026 annual meeting of shareholders on April 29 in a virtual format, with Chairman Dr. Robert Zerbe presiding. Zerbe said the meeting was conducted pursuant to Michigan law, the company's bylaws, and the notice distributed to shareholders. Sean Flynn, Vericel's corpora...

Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Vericel Corporation (NASDAQ:VCEL - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are presently covering the stock, MarketBeat.com reports...

Vericel (NASDAQ:VCEL) Shares Down 7.1% - Time to Sell?

Vericel (NASDAQ:VCEL) Trading Down 7.1% - What's Next...

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Vericel Corp

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$42.53
Prev Close	$42.97
Open	$42.99
Dividend Yield	0.00%
50-Day Moving Average	$40.72
Beta	1.13
Avg. Volume	503,303.75
PE Ratio	92.02

52-Week High	$49.32
52-Week Low	$28.95
Market Capitalization	$2.18B
EPS (Annual)	$0.3167
Price to Book	5.88
Revenue Per Employee	$694,118.09

Feed

News

Sentiment

Earnings

Fundamentals

Info

VCEL Fundamentals